Apr 12, 2024
FDA
The new article outlines the general considerations associated with the Q-Submission Program to facilitate the process of obtaining feedback from the authority concerning regulatory submissions.
Read More
Apr 12, 2024
FDA
The new article provides a general overview of the Q-submission process as the relevant legislation prescribes.
Read More
Apr 12, 2024
FDA
The new article describes potential questions to be discussed with the authority in the context of the Q-Submission Program interactions.
Read More
Apr 8, 2024
FDA
The article provides a general overview of the revised guidance document and highlights the key points related to the existing legal framework.
Read More
Apr 8, 2024
FDA
The new article pays attention to the general questions associated with Q-Submissions that medical device manufacturers may use to request additional feedback from the authority before submitting an actual application for marketing approval.
Read More